General and gender characteristics of type 2 diabetes mellitus among the younger and older age groups

Oman Medical Journal

Volumn 27, Issue 5, 2012, Pages 375-382

  Al Mukhtar, Samir Burhanaldin ^a   Fadhil, Nabeel Najib ^a   Hanna, Bassam Edward ^a  

^a UNIVERSITY OF MOSUL   (Iraq)

Author keywords

Age; Cardiovascular risk factors; Dyslipidemia; Fasting plasma glucose; HbA1c ; Lipid profile; Smoking; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIET RESTRICTION; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; QUESTIONNAIRE; SMOKING; SOCIAL STATUS;

EID: 84867665984     PISSN: 1999768X     EISSN: 20705204     Source Type: Journal    
DOI: 10.5001/omj.2012.94     Document Type: Article

References (59)

1. Berry C, Tardif JC, Bourassa MG. Coronary heart disease in patients with diabetes: part I: recent advances in prevention and noninvasive management. J Am Coll Cardiol 2007 Feb;49(6):631-642.
2. Reddy KS. Cardiovascular disease in non-Western countries. N Engl J Med 2004 Jun;350(24):2438-2440.
3. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008 Jan;117(4):e25-e146.
4. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002 Dec;106(25):3143-3421.
5. Powers AC. Diabetes mellitus, In: Harrison's principles of internal medicine. Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL, Loscalzo J. Eds. 17th edition. McGraw-Hill, New York. 2008: 2275-2279.
6. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004 Jan;27(1)(Suppl 1):S5-S10.
7. Vergès B. Lipid modification in type 2 diabetes: the role of LDL and HDL. Fundam Clin Pharmacol 2009 Dec;23(6):681-685.
8. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004 Mar;27(3):813-823.
9. Montori VM, Fernández-Balsells M. Glycemic control in type 2 diabetes: time for an evidence-based about-face? Ann Intern Med 2009 Jun;150(11):803-808.
10. Hyvärinen M, Tuomilehto J, Laatikainen T, Söderberg S, Eliasson M, Nilsson P, et al. The impact of diabetes on coronary heart disease differs from that on ischaemic stroke with regard to the gender. Cardiovasc Diabetol 2009;8:17.
11. Kanaya AM, Grady D, Barrett-Connor E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med 2002 Aug;162(15):1737-1745.
12. Lee WL, Cheung AM, Cape D, Zinman B. Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care 2000 Jul;23(7):962-968.
13. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004 Sep;364(9438):937-952.
14. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006 Jan;332(7533):73-78.
15. Ezenwaka CE, Offiah NV. Differences in cardiovascular disease risk factors in elderly and younger patients with type 2 diabetes in the West Indies. Singapore Med J 2002 Oct;43(10):497-503.
16. Gunathilake S, Song S, Sridharan DJ, Fernando, Idris I. Cardiovascular and metabolic risk profiles in young and old patients with Type 2 diabetes. QJM; First published online guidelines for controlling and monitoring the tobacco epidemic. Geneva: July 30, 2010.
17. Guidelines for controlling and monitoring the tobacco epidemic. Geneva World Health Organization 1998.
18. Obesity-preventing and managing the global epidemic: report of a WHO consultation on obesity. Geneva, World Health Organization, 1998.
19. World Health Organization (WHO). Physical Status: the use and interpretation of anthropometry. Geneva: WHO, 1995. (Technical Report Series, 854).
20. Wood D, Durrington P, Poulter N. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998;80(Suppl.2):1-29.
21. Bloomfield P, Bradbury A, Grubb NR, Newby DE. Cardiovascular diseases. In Davidson's Principles and Practice of Medicine. Boon NA, Colledge NRP and Walker BR Eds. 20th ed. Churchill Livingstone. Edinburgh 2006. 519-646.
22. American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care 2007;1:S4-S5.
23. WHO-1993 EM/DIA. 3/E/G cited by Mansour AA. Type 2 diabetes mellitus: presentations, complication and treatment. Med J Basrah Univ 2002;20(1):41-47.
24. Stanbio. Glycohemoglobin procedure: principles, application and comparisons. East Houston Street, San Antonio, USA 2003; 1-20.
25. Awtry EH, Locscalo J. Coronary heart disease. In: Cecil Essential of Medicine. Capenter C; Griggs RC; and Locscalo J, Eds. 6th ed. Elsevier Saunders Inc. Philadelphia 2004: 87-173.
26. Sacks DB. Carbohydrates. In: Burtis CA, Ashood ER, Bruns DE, Eds. In Teitz Fundamentals of Clinical Chemistry. 6th ed. 2008: WB Saunders Philadelphia. 373-401.
27. Moore JC, Bown E, Outlaw MC, Jelfs R, Holman RR, Turner RC. Glycosylated haemoglobin: comparison of five different methods, including measurement on capillary blood samples. Ann Clin Biochem 1986 Jan;23(Pt 1):85-91.
28. Rifai N. Lipids, lipoproteins, aoplipoprotiens and other cardiovascular risk factors. In: Teitz Fundamentals of Clinical Chemistry. Burtis CA, Ashood ER and Bruns DE, Eds. 6th ed. WB Saunders. Philadelphia. 2008:402-430.
29. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem 1972;18:449-552.
30. Gholap N, Davies M, Patel K, Sattar N, Khunti K. Type 2 diabetes and cardiovascular disease in South Asians. Prim Care Diabetes 2011 Apr;5(1):45-56.
31. Zhan Y, Yuan L, Oettgen P. Alterations in transcriptional responses associated with vascular aging. J Inflamm (Lond) 2009;6:16.
32. Stamler J, Neaton JD, Wentworth DN. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension 1989 May;13(5) (Suppl):I2-I12.
33. Kannel WB, Neaton JD, Wentworth D, Thomas HE, Stamler J, Hulley SB, et al. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial. Am Heart J 1986 Oct;112(4):825-836.
34. Kawasumi M, Tanaka Y, Uchino H, Shimizu T, Tamura Y, Sato F, et al. Strict glycemic control ameliorates the increase of carotid IMT in patients with type 2 diabetes. Endocr J 2006 Feb;53(1):45-50.
35. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J (Clin Res Ed) 1983 Sep;287(6396):867-870.
36. Selvin E, Wattanakit K, Steffes MW, Coresh J, Sharrett AR. HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2006 Apr;29(4):877-882.
37. Chien KL, Hsu HC, Su TC, Chen MF, Lee YT, Hu FB. Fasting and postchallenge hyperglycemia and risk of cardiovascular disease in Chinese: the Chin-Shan Community Cardiovascular Cohort study. Am Heart J 2008 Nov;156(5):996-1002.
38. Berg JE, Høstmark AT. Cardiovascular risk determination: discrepancy between total cholesterol evaluation and two compound laboratory indices in Norway. J Epidemiol Community Health 1994 Aug;48(4):338-343.
39. Real JT, Chaves FJ, Martínez-Usó I, García-García AB, Ascaso JF, Carmena R. Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia. Eur Heart J 2001 Mar;22(6):465-471.
40. U.K. Prospective Diabetes Study 27. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex. Diabetes Care 1997 Nov;20(11):1683-1687.
41. Toner JM, Close CF, Ramsay LE. Factors related to treatment resistance in hypertension. Q J Med 1990 Nov;77(283):1195-1204.
42. Janssen I, Katzmarzyk PT, Ross RS. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 2004 Mar;79(3):379-384.
43. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al; American Heart Association; Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weigHt. loss: an update of the 1997 American Heart Association scientific statement on obesity and heart disease from the Obesity Committee of the council on nutrition, physical activity, and metabolism. Circulation 2006 Feb;113(6):898-918.
44. Ostlund RE Jr, Staten M, Kohrt WM, Schultz J, Malley M. The ratio of waist-to-hip circumference, plasma insulin level, and glucose intolerance as independent predictors of the HDL2 cholesterol level in older adults. N Engl J Med 1990 Jan;322(4):229-234.
45. Peter L. Prevention and treatment of atherosclerosis. In: Harrison's principles of internal medicine. Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser S, Jameson FL, Eds. 16th edition. McGraw-Hill, New York. 2005: 1432.
46. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA 1999 Apr;281(14):1291-1297.
47. Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, Lee ET. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Diabetes Care 1998 Aug;21(8):1258-1265.
48. Petitti DB, Imperatore G, Palla SL, Daniels SR, Dolan LM, Kershnar AK, et al; SEARCH for Diabetes in Youth Study Group. Serum lipids and glucose control: the SEARCH for Diabetes in Youth study. Arch Pediatr Adolesc Med 2007 Feb;161(2):159-165.
49. Walden CE, Knopp RH, Wahl PW, Beach KW, Strandness E Jr. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N Engl J Med 1984 Oct;311(15):953-959.
50. Juutilainen A, Kortelainen S, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 2004 Dec;27(12):2898-2904.
51. Siegel RD, Cupples A, Schaefer EJ, Wilson PW. Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study. Metabolism 1996 Oct;45(10):1267-1272.
52. Moy CS, LaPorte RE, Dorman JS, Songer TJ, Orchard TJ, Kuller LH, et al. Insulin-dependent diabetes mellitus mortality. The risk of cigarette smoking. Circulation 1990 Jul;82(1):37-43.
53. Park MH, Kim N, Lee JY, Park HY. Genetic loci associated with lipid concentrations and cardiovascular risk factors in the Korean population. J Med Genet 2011 Jan;48(1):10-15.
54. Luft FC. Twins in cardiovascular genetic research. Hypertension 2001 Feb;37(2 Part 2):350-356.
55. Batra V, Patkar AA, Berrettini WH, Weinstein SP, Leone FT. The genetic determinants of smoking. Chest 2003 May;123(5):1730-1739.
56. de Castro JM, Lilenfeld LR. Influence of heredity on dietary restraint, disinhibition, and perceived hunger in humans. Nutrition 2005 Apr;21(4):446-455.
57. Jeong SU, Kang DG, Lee DH, Lee KW, Lim DM, Kim BJ, et al. Clinical characteristics of type 2 diabetes patients according to family history of diabetes. Korean Diabetes J 2010 Aug;34(4):222-228.
58. Chen JH, Huang HH, Yen DH, Wu YL, Wang LM, Lee CH. Different clinical presentations in chinese people with acute myocardial infarction in the emergency department. J Chin Med Assoc 2006 Nov;69(11):517-522.
59. Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N. Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch Intern Med 2011 Mar;171(5):404-410.